FDA Approves Botox for Treatment of Migraines
The Food and Drug Administration has approved Botox anti-wrinkle injection for the treatment of chronic migraine headaches. Adult sufferers would receive injections around the head and neck once every twelve weeks in order to dull future headaches.
The FDA defines chronic migraine symptoms as having a headache on most days of the month. Botox has not been demonstrated to work for those who suffer with a headache for 14 days or less each month. Check the source link to read the FDA news release. Source
The FDA defines chronic migraine symptoms as having a headache on most days of the month. Botox has not been demonstrated to work for those who suffer with a headache for 14 days or less each month. Check the source link to read the FDA news release. Source
Comments